Picture Fairtec GmbH Worldwide Event Solutions 600x60px
Document › Details

Bayer AG. (10/2/14). "Press Release: Company Further Strengthens Its Crop Protection Portfolio – Bayer CropScience Acquires European Distribution Rights for Biofungicide Contans from Belchim Crop Protection". Monheim.

Region Region Europe
Organisations Organisation Bayer CropScience AG
  Group Bayer (Group)
  Organisation 2 Belchim Crop Protection N.V.
Products Product Contans™ WG biofungicide
  Product 2 biological crop protection product
Index term Index term Bayer–Belchim Crop Protection: fungicide, 201410– acquisition sole European distribution rights €na for biofungicide Contans WG by Bayer CropScience
Person Person Miille, Mike (Bayer 201410 Head of Business Management Biologics at Bayer CropScience before AgraQuest)

Bayer CropScience announced today that it has acquired the sole European distribution rights for the biological fungicide Contans™ WG from Belchim Crop Protection NV effective October 1, 2014. This acquisition further strengthens Bayer CropScience’s crop protection portfolio and is another step in building up a comprehensive range of biologicals as part of integrated crop solutions. The transfer of the business is planned to take a phased approach, country by country, over the coming 12 months starting November 1, 2014. Financial details were not disclosed.

Together with seeds, chemical crop protection products, services and proactive stewardship measures, biologicals constitute Bayer CropScience’s response to customer needs. “This acquisition means we will be able to offer European farmers another established biological solution to combat fungal diseases in arable and vegetable crops,” said Mike Miille, Head of Business Management Biologics at Bayer CropScience. “We will further develop integrated crop solutions hand-in-hand with farmers combining our wide range of innovative chemicals with strong biological brands like Votivo™, Serenade™ and Sonata™. As part of integrated spray plans, Contans™ WG will help to increase yields and boost the quality of harvested produce.”

Following its successful market introduction by Belchim Crop Protection, based in Londerzeel, Belgium, Contans™ WG has become one of the biggest biological fungicides currently used in conventional agriculture in Europe and is widely recognized as a model for success in the biocontrol market.

Contans™ WG is presently commercialized in major European agricultural markets such as France, Germany, the United Kingdom and Ireland, Belgium, the Netherlands, Italy, Spain, Portugal, Hungary, the Czech Republic, Slovakia and Poland.

The product is used in a variety of crops such as oilseed rape, sunflowers and various vegetable crops and pulses, as a soil treatment product in the open field or in greenhouses. Contans™ WG contains the highly active spores of the soil fungus Coniothyrium minitans (strain CON/ M/91-08), which effectively attacks the surviving structures (sclerotia) of the plant pathogens Sclerotinia spp. in the soil.

About Bayer CropScience

Bayer is a global enterprise with core competencies in the fields of health care, agriculture and high-tech materials. Bayer CropScience, the subgroup of Bayer AG responsible for the agricultural business, has annual sales of EUR 8,819 million (2013) and is one of the world’s leading innovative crop science companies in the areas of seeds, crop protection and non-agricultural pest control. The company offers an outstanding range of products including high value seeds, innovative crop protection solutions based on chemical and biological modes of action as well as an extensive service backup for modern, sustainable agriculture. In the area of non-agricultural applications, Bayer CropScience has a broad portfolio of products and services to control pests from home and garden to forestry applications. The company has a global workforce of 22,400 and is represented in more than 120 countries. This and further news is available at:

Find more information at

Forward-Looking Statements

This release may contain forward-looking statements based on current assumptions and forecasts made by Bayer Group or subgroup management. Various known and unknown risks, uncertainties and other factors could lead to material differences between the actual future results, financial situation, development or performance of the company and the estimates given here. These factors include those discussed in Bayer’s public reports which are available on the Bayer website at The company assumes no liability whatsoever to update these forward-looking statements or to conform them to future events or developments.

Record changed: 2017-04-02


Picture [LSUS] – The Business Web Portal 600x60px

More documents for Bayer (Group)

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]


SilverSky LifeSciences DxPx Conference 2019 Düsseldorf Medica 600x60px

» top